Coloplast A/S represents values of compassion, innovation, and responsibility in its corporate philosophy. As a global healthcare company specializing in medical products and services, Coloplast A/S is dedicated to improving the lives of individuals with intimate healthcare needs. The company emphasizes care and understanding towards its customers, striving to develop innovative solutions that enhance their quality of life. Coloplast A/S's commitment to responsible business practices is reflected in its focus on sustainability, ethics, and transparency. With its strong emphasis on compassion, innovation, and responsibility, Coloplast A/S stands as a leading healthcare company, providing essential products and services to improve the well-being of individuals worldwide.

Coloplast A/S is primarily present in a diverse range of countries and regions worldwide. The company has a strong global presence, serving markets in Europe, North America, Latin America, Asia-Pacific, the Middle East, and Africa. With a focus on providing innovative medical solutions, Coloplast A/S has established its footprint in numerous countries, including the United States, Germany, France, China, Japan, Brazil, Australia, and South Africa. Through its widespread reach, Coloplast A/S ensures that its advanced healthcare products and services are accessible to patients and healthcare professionals across different regions, contributing to improved quality of life and better healthcare outcomes.

Coloplast A/S, a leading medical device company, has achieved several significant milestones throughout its history. The company has a strong track record of innovation and has consistently introduced groundbreaking products to the market. Coloplast A/S introduced the world's first disposable ostomy appliance in 1954, revolutionizing care for ostomy patients. In recent years, the company has focused on expanding its product portfolio in urology and continence care, bringing advanced solutions to patients suffering from bladder and bowel dysfunctions. With a commitment to improving the quality of life for individuals with intimate healthcare needs, Coloplast A/S continues to make strides in the medical device industry.

Coloplast A/S is a renowned Danish medical device company specializing in developing and manufacturing products for ostomy care, urology, continence care, and wound care. Founded in 1957, Coloplast has established itself as a global leader in its field, serving patients in more than 140 countries. With a strong focus on innovation, Coloplast continuously strives to improve the quality of life for individuals with intimate healthcare needs. The company's success is attributed to its commitment to customer-centricity and its ability to anticipate and adapt to changing market demands. Over the years, Coloplast has consistently delivered innovative solutions and has built a reputation for providing exceptional products and services in the healthcare industry.

The main competitors of Coloplast A/S in the market include Medtronic, Hollister Incorporated, and Convatec.

Coloplast A/S is primarily active in the healthcare industry.

The business model of Coloplast A/S revolves around developing and manufacturing medical devices and services that cater to the needs of individuals with intimate healthcare needs. As a leading global supplier, Coloplast focuses on urology, ostomy, continence, wound care, and skin care products. By constantly innovating and collaborating with healthcare professionals, Coloplast aims to improve the quality of life for patients worldwide. With its customer-centric approach, the company provides advanced medical solutions, education, and support to help individuals regain their independence and confidence. Coloplast A/S is committed to delivering high-quality products and services that empower individuals to live an active and fulfilling life.

Coloplast A/S KGV ir 39,64.

Coloplast A/S KUV ir 6,89.

AlleAktien kvalitātes vērtējums Coloplast A/S ir 6/10.

gaidāmā Coloplast A/S apgrozījums ir 27,25 miljardi DKK.

gaidāmā Coloplast A/S peļņa ir 4,74 miljardi DKK.

Coloplast A/S is a global company specializing in the development, manufacture, and distribution of medical devices and healthcare products. The company is divided into different business areas that focus on different customer needs. Its main business areas include continence care, wound care, and surgical products. Coloplast also offers products and services for animal continence care and wound care. The company is committed to providing high-quality products and improving patient care through innovation and collaboration with healthcare professionals. Coloplast operates in over 100 countries worldwide and strives to be a leading provider in the healthcare market.

Coloplast A/S izmaksā dividendes 20,00 DKK, kas tiek izmaksātas 2 reizes gadā.

Coloplast A/S izmaksā dividendes 2 reizes gadā.

Coloplast A/S ISIN ir DK0060448595.

Coloplast A/S WKN ir A1KAGC.

Coloplast A/S simbols ir COLO B.CO.

Pēdējo 12 mēnešu laikā Coloplast A/S maksāja dividendes 21,00 DKK apmērā. Tas atbilst aptuveni 2,41 % dividendes ražībai. Nākamajos 12 mēnešos Coloplast A/S plāno maksāt dividendes 22,32 DKK apmērā.

Coloplast A/S pašreizējā dividendu rentabilitāte ir 2,41 %.

Coloplast A/S maksā dividendes ceturksnī. Tās tiek izmaksātas mēnešos janvāris, jūnijs, janvāris, jūnijs.

Coloplast A/S pēdējo 0 gadu laikā katru gadu izmaksāja dividendes.

Nākamajiem 12 mēnešiem tiek prognozētas dividendes apmērā 22,32 DKK. Tas atbilst dividendes ražībai 2,56 %.

Coloplast A/S tiek piešķirts nozarei "Veselība".

Lai saņemtu pēdējo dividendu Coloplast A/S apmērā 5 DKK, kas tika izmaksāta 15.05.2024., tev akcija bija jāpatur depozītā līdz Ekss dienai, kas bija 13.05.2024..

Pēdējās dividendes izmaksa notika 15.05.2024..

Gadā 2023, Coloplast A/S izmaksāja 20 DKK dividendes.

Coloplast A/S dividendes tiek izmaksātas DKK.